Timothy Hoey, SVP, Cancer Biology & Co-CSO at OncoMed Pharmaceuticals Inc (OMED), sold 12,500 shares at $9.89 ($124K) on 2016-11-16, disclosed to the SEC on 2016-11-18.
Open-market sale of $124k OMED by SVP, Cancer Biology & Co-CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TNYA | SELL | 2024-02-16 | $27K | — | Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |